z-logo
open-access-imgOpen Access
Hepatic HKDC1 Expression Contributes to Liver Metabolism
Author(s) -
Carolina M. Pusec,
Adam De Jesus,
Md. Wasim Khan,
Alexander R. Terry,
Anton E. Ludvik,
Kai Xu,
Nicholas Giancola,
Haaris Pervaiz,
Emily Daviau Smith,
Xianzhong Ding,
Stephen A. Harrison,
Navdeep S. Chandel,
Thomas Becker,
Nissim Hay,
Hossein Ardehali,
José CórdobaChacón,
Brian T. Layden
Publication year - 2018
Publication title -
endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.674
H-Index - 257
eISSN - 1945-7170
pISSN - 0013-7227
DOI - 10.1210/en.2018-00887
Subject(s) - endocrinology , glucokinase , medicine , hexokinase , biology , lipid metabolism , mitochondrion , glycolysis , carbohydrate metabolism , steatosis , metabolism , nonalcoholic fatty liver disease , glucose homeostasis , fatty liver , biochemistry , diabetes mellitus , insulin resistance , disease
Glucokinase (GCK) is the principal hexokinase (HK) in the liver, operating as a glucose sensor to regulate glucose metabolism and lipid homeostasis. Recently, we proposed HK domain-containing 1 (HKDC1) to be a fifth HK with expression in the liver. Here, we reveal HKDC1 to have low glucose-phosphorylating ability and demonstrate its association with the mitochondria in hepatocytes. As we have shown previously that genetic deletion of HKDC1 leads to altered hepatic triglyceride levels, we also explored the influence of overexpression of HKDC1 in hepatocytes on cellular metabolism, observing reduced glycolytic capacity and maximal mitochondrial respiration with concurrent reductions in glucose oxidation and mitochondrial membrane potential. Furthermore, we found that acute in vivo overexpression of HKDC1 in the liver induced substantial changes in mitochondrial dynamics. Altogether, these findings suggest that overexpression of HKDC1 causes mitochondrial dysfunction in hepatocytes. However, its overexpression was not enough to alter energy storage in the liver but led to mild improvement in glucose tolerance. We next investigated the conditions necessary to induce HKDC1 expression, observing HKDC1 expression to be elevated in human patients whose livers were at more advanced stages of nonalcoholic fatty liver disease (NAFLD) and similarly, found high liver expression in mice on diets causing high levels of liver inflammation and fibrosis. Overall, our data suggest that HKDC1 expression in hepatocytes results in defective mitochondrial function and altered hepatocellular metabolism and speculate that its expression in the liver may play a role in the development of NAFLD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom